However, we did not find clear phenotypic consequences of the proposed impact of rs150550023 genotype upon regulation of the p53-MDM2 hub with respect to cancer risk, age of onset, rate of TP53 mutation, or survival. The gene discussed is MDM2; the disease is cancer.